|
|
||||||||
-Hydroxysteroid Dehydrogenase Type 1-Deficient Mice Exhibit an Increased Sensitivity to Lipopolysaccharide Stimulation Due to TGF-
-Mediated Up-Regulation of SHIP1 ExpressionDepartment of Pathology, School of Medicine, University of Utah, Salt Lake City, UT 84132
11
-Hydroxysteroid dehydrogenase type 1 (11
HSD1) performs end-organ metabolism of glucocorticoids (GCs) by catalyzing the conversion of C11-keto-GCs to C11-hydroxy-GCs, thereby generating activating ligands for the GC receptor. In this study, we report that 11
HSD1–/– mice are more susceptible to endotoxemia, evidenced by increased weight loss and serum TNF-
, IL-6, and IL-12p40 levels following LPS challenge in vivo. Peritoneal and splenic macrophage (splnM
) from these genetically altered mice overproduce inflammatory cytokines following LPS stimulation in vitro. Inflammatory cytokine overexpression by 11
HSD1–/– splnM
results from an increased activation of NF-
B- and MAPK-signaling cascades and an attenuated PI3K-dependent Akt activation. The expression of SHIP1 is augmented in 11
HSD1–/– M
and contributes to inflammatory cytokine production because overexpression of SHIP1 in primary bone marrow M
(BMM
) leads to a similar type of hyperresponsiveness to subsequent LPS stimulation. 11
HSD1+/+ and 11
HSD1–/– BMM
responded to LPS similarly. However, 11
HSD1–/– BMM
derived in the presence of elevated GC levels up-regulated SHIP1 expression and increased their capacity to produce inflammatory cytokines following their activation with LPS. These observations suggest the hyperresponsiveness of 11
HSD1–/– splnM
results from myeloid cell differentiation in the presence of moderately elevated GC levels found within 11
HSD1–/– mice. GC-conditioning of BMM
enhanced SHIP1 expression via up-regulation of bioactive TGF-
. Consistently, TGF-
protein expression was increased in unstimulated CD11b– cells residing in the BM and spleen of 11
HSD1–/– mice. Our results suggest that modest elevations in plasma GC levels can modify the LPS responsiveness of M
by augmenting SHIP1 expression through a TGF-
-dependent mechanism.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Address correspondence and reprint requests to Dr. Raymond A. Daynes, Department of Pathology, 5B412 School of Medicine, University of Utah, 30 North 1900 East, Salt Lake City, UT 84132-2501. E-mail address: daynes.office{at}path.utah.edu
2 Abbreviations used in this paper: GC, glucocorticoid; GR, GC receptor; GRE, GC response element; 11BHSD1, 11
-hydroxysteroid dehydrogenase type 1; M
, macrophage; BM, bone marrow; WT, wild type; PEM
, peritoneal-elicited M
; splnM
, splenic M
; PIP3, PI(3,4,5)P3.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |